A real-world pharmacovigilance study of FDA adverse event reporting system events for diazepam
Conclusion: Our study identified potential signals of new AEs that could provide strong support for clinical monitoring and risk identification of diazepam.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Anxiety | Databases & Libraries | Diazepam | Drugs & Pharmacology | Epilepsy | Men | Rhabdomyolysis | Study | Valium